SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-23-001715
Filing Date
2023-01-17
Accepted
2023-01-17 06:08:27
Documents
9

Document Format Files

Seq Description Document Type Size
1 425 ny20006674x1_8k.htm 425 49768
2 EXHIBIT 2.1 ny20006674x1_ex2-1.htm EX-2.1 876717
3 EXHIBIT 10.1 ny20006674x1_ex10-1.htm EX-10.1 55437
4 EXHIBIT 10.2 ny20006674x1_ex10-2.htm EX-10.2 57186
5 EXHIBIT 10.3 ny20006674x1_ex10-3.htm EX-10.3 61254
6 EXHIBIT 10.4 ny20006674x1_ex10-4.htm EX-10.4 23549
7 EXHIBIT 99.1 ny20006674x1_ex99-1.htm EX-99.1 26759
8 ny20006674x1_ex99-1img01.jpg GRAPHIC 4227
9 ny20006674x1_ex99-1img02.jpg GRAPHIC 3619
  Complete submission text file 0001140361-23-001715.txt   1163305
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filed by) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39990 | Film No.: 23530095
SIC: 2834 Pharmaceutical Preparations